MaxCyte inks commercial licensing agreement with Apeiron Biologics
Pharmaceutical technology supplier MaxCyte said it had entered into a clinical and commercial licensing agreement with private biotechnology company Apeiron Biologics.
Apeiron Biologics would obtain...
Wed, 08/07/2020 - 08:57